Navigated to Fremanezumab for the Treatment of Migraine and Major Depressive Disorder
Get the app

Log in
JAMA Neurology Author Interviews

Fremanezumab for the Treatment of Migraine and Major Depressive Disorder

May 5, 2025
21 mins

View Transcript

Episode Description

Interview with Richard B. Lipton, MD, author of Fremanezumab for the Treatment of Patients With Migraine and Comorbid Major Depressive Disorder. Hosted by Cynthia E. Armand, MD.

Related Content:

See all episodes

Never lose your place, on any device

Create a free account to sync, back up, and get personal recommendations.

Create account